Pharmaceuticals, Biotechnology and Life Sciences
OXFORD, United Kingdom, May 04, 2021 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the…
SAN CARLOS, Calif., May 04, 2021 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel…
New Drug Application (NDA) submission for topical roflumilast cream as a potential treatment for plaque psoriasis anticipated in the second…
Multiple pre-clinical studies indicate that Lixte’s lead clinical drug candidate LB-100 enhances the effectiveness of many standard anticancer treatments EAST…
ERYTECH Provides Business Update and Reports Financial Results for the First Quarter of 2021 Conference call and webcast on Wednesday,…
SEATTLE, May 04, 2021 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development…
REDWOOD CITY, Calif., May 04, 2021 (GLOBE NEWSWIRE) — Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive…
COPENHAGEN, Denmark, May 04, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative…
Novel candidate in development aims to be first approved non-vaccine therapeutic for Lyme disease prevention Allows initiation of Phase 1…
MORRISVILLE, N.C., May 03, 2021 (GLOBE NEWSWIRE) — Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only…